Rani Therapeutics Holdings Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 105.35x

Rani Therapeutics Holdings Inc cash flow reinvestment rate. Rani Therapeutics Holdings Inc (RANI) has a Cash Flow Reinvestment Rate of 105.35x as of December 2025, reinvesting $30.97 Million (capex $0.00 plus investments $-30.97 Million) from operating cash flow of $294.00K. Explore debt repayment capacity of Rani Therapeutics Holdings Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

105.35x
(Capex + Investments) / Operating CF

Total Reinvested

$30.97 Million
Capex + Investments

Operating Cash Flow

$294.00K
USD

Capital Expenditures

$0.00
USD

Rani Therapeutics Holdings Inc Cash Flow Reinvestment Rate by Year (None–None)

Rani Therapeutics Holdings Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Rani Therapeutics Holdings Inc. For the full cash flow conversion analysis, see Rani Therapeutics Holdings Inc cash conversion from operations.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow